developments in therapies for aml - chemotherapy, targeted therapy and immunotherapy
Published 7 years ago • 1.1K plays • Length 4:20Download video MP4
Download video MP3
Similar videos
-
0:36
the potential of immunotherapies in the myeloma treatment landscape
-
0:59
developing lsc-targeting agents in aml: progress and current therapeutic capacity
-
2:29
epitope editing enables the use of novel immunotherapies for aml
-
2:33
novel immunotherapies in aml and insights into the future of the treatment landscape
-
3:47
the role of immunotherapy in the aml treatment landscape
-
2:26
insights into the future of aml therapy: the increasing use of targeted agents
-
2:58
what new treatments are in development for aml?
-
4:58
overview of the toxicities associated with bispecific agents in multiple myeloma
-
2:38
session highlights: transforming aml treatment and building on new approaches
-
3:26
developments in the treatment of patients with flt3-mutated aml
-
2:34
the evolution of the aml treatment paradigm
-
1:54
new developments in aml treatment
-
1:29
the current landscape of immunotherapy for aml: an update from ash 2023
-
7:52
advances in aml understanding: apl therapy, immunotherapy and maintenance therapy
-
5:25
how the aml treatment landscape is changing with the introduction of novel targeted agents
-
2:49
maintenance therapy in aml: agents under investigation and future outlooks
-
1:39
optimizing chemotherapy in aml
-
1:42
novel treatment combinations in aml: what’s to come?
-
3:40
how the aml treatment landscape has evolved with the use of novel combination therapies